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SUMMARY.-When normal rat and mouse embryo cells were treated with
a cell free extract of S37 ascites tumour, morphological transformations
occurred in both. The transformed cells readily induced lymphosarcoma-type
tumours in the mice inoculated when newborn oryoung adults (8-12 weeksold), but not so readily in rats.
Various tests carried out with these cells strongly indicate the presence of an
oncogenic and transmissible agent in S37 ascites tumour. This agent appears
to be related to mouse sarcoma virus isolated from an'lmals with Moloney leukaemia but differs in only producing characteristic lymphosarcoma-type
tumours.
THE murine sarcoma viruses (MSV) isolated from animals withMoloneyleukae-
mia are known to induce sarcomas in rats and mice. The changes induced by MSV in cells cultured in vitro have been often reported. This article describes
for the first time the changes induced by a cell-free extract of S37 ascites tumour,
or by cell-free asciticfluid/plasma ofthe tumour, from BALB/c mice. Morpholo- gical transformation occurred both in rat and mouse embryo cells in vitro and
various tests carried out with these cells strongly suggest the presence of an
oneogenic agent(s) in the S37 ascites tumour.
MATERIALS AND METHODS
Animals used throughout this work were inbred BALB/c mice and Wistar
or Sprague-Dawley rats.
S37 tumour was maintained in young adultBALB/c mice andseriallypassaged by intraperitoneal injection of the ascites fluid at intervals of 10-12 days. For
experimental use the tumour was aspirated 8-10 days after inoculation and left
at room temperature for 15--20 minutes, when a clot was formedseparating ascitic
plasma/serum from the cells. The mixture was centrifuged at 1400g for 30
minutes in aswing head centrifuge (MSE) and the supernatant was again spun for
20 minutes and filtered through an 0.45 It membrane filter (" Millipore "). In
most of the experiments, after separating blood cells from the ascites tumour, a
5% suspension of the tumour cells was made in 0-153 m potassium citrate and
were then either homogenized in a Waring blender or ultrasonically vibrated for
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about a minute to break the cell membranes. The homogenate was centrifuged
for 20 minutes at 2300 g and the supernatant was recentrifuged for 2 minutes at
1000 g. The fluid was then filtered through an 0-45/t
" Millipore
" filter and
used for treating the cell cultures. The extracts were normally made fresh for
each experiment but on a few occasions when it was used after 3 to 4days storage
at 4' C. the infectivity was slightly impaired.
To test the transmissibility ofthe agent an extract ofthe in vitro transformed
cells was prepared in a similar way to that described above for S37 tumour. A
filtrate ofthe normal untreated cells was used as a
" control
" for thisexperiment.
Monolayer cultures werepreparedbytrypsinizing 14 to 15 day old eviscerated
and decapitated embryos and growing them in 70% medium
" 199
" (Glaxo
Laboratories), 15% Earle's solution and 14% calf serum. About 0-36 mg./ml.
of glutamine, 250 units/ml. of penicillin, 55 units/ml. of streptomycin and 50
units/ml. of Nystatin were also added to the final concentration of the medium.
Instead ofwhole-embryo cells, rat embryo-lung cultures were used on two occa-
sions. Approximately 5 x 105 cells were grown in each Carrel flask or on glass
coverslips in hexagonal roller tubes in a rotating drum.
After about 24 hr the cell sheet showed some areas of confluence but there
were stillempty spaces between most cells. At this timetheexperimental cultures
were treated with S37 ascites tumour extract diluted in the normal nutrient
medium. About 12 ml. ofthis mixture was used to treat the cultures in the Carrel
flasks and 5 ml. for those in the roller tubes. The untreated cultures were used as
controls and were maintained on the same volume of the standard medium per
culture vessel as the treated ones. After incubation overnight the medium was
replaced with the same volume of fresh medium (without the tumour extract).
For the cultures that were treated more than once the medium was replaced by a
fresh dilution of S37 extract in the normal medium. The cultures, however,
were notwashedbefore or after the treatment. Asingle dose of 4% ofthe extract
or plasma in the medium was sufficient to induce alterations but four consecutive
daily treatments of I% dilution were found to be more efficient than a single dose (Table 1). The cultures were incubated at 37' C. but not in a humidified
atmosphere containing C02 in air. They were therefore fed daily with normal
growth medium. Untreated cultures were used as
" controls ".
TABLEI.-Focus Formation by the S37 Extract inPrimary Embryo Cell
Cultures In Vitro
Embryo cell cultures
Dilution of tumour
extract in nutrient BALB/c, Sprague-Dawley medium Golden hamster and Wistar
I : 25 (I treatment) Only cytopathic changes All transformed after
(not confirmed) 4-41 weeks
1 : 50 (2 treatments) Only cytopathic changes All transformed after
(not confirmed) 3j--4 weeks
I : 100 (4 treatments) Only cytopathic changes All transformed after
(not confirrned) 3J-4 weeks
Control (no treatment) No effect No change
Formicroscopical examination cultures on the coverslips were fixed in
" Susa
and were stained with May-Griinwald Giemsa.144 S.RASHEED
EXPERIMENTAL RESULTS
In about three weeks the cultures had undergone four to five subeultivations
(trypsinization) and the growth of cells had diminished considerably. At this
time a number of small foci appeared in infected cultures of both rat and mouse
embryo cells. The number of foci in rat and mouse cells was dose-dependent.
Although a single dose contained the same volume of extract as the four separate
doses, more foci seemed to haveappearedwiththelatterdosethanwiththe former.
The foci were scattered throughout a sheet ofapparently normal cells and when
stained with Giemsaappeared as moredenselystaining areasagainst abackground
of lighter staining cells' The medium on these altered cells was more rapidly
acidified than that on the normal control cultures.
As the cultures were grown on coverslips in the roller tubes it was not possible
to countaccuratelythe number ofaltered cells in eachtitration, butapproximately
2-3% ofthe cellpopulation in each roller tube seemed to have altered first and the
rest of the normal cells either lysed or degenerated as the transformed cells pro-
gressively grew in cultures.
The transformed cells had a capacity for rapid proliferation and had greater
proportion of nuclear mass to cytoplasm and larger average number of nucleoli
per nucleus. Cytoplasmic basophilia increased tremendously and with Feulgen
staining it was estimated that there was more DNA content in altered cells than in
normal cells. In contrast, the normal untreated ceRs were not so basophilic
and nuclei were simple, having 2-4 nucleoli per nucleus with very few chromatin
granules.
Various tests were carried out to see if the transformations were irreversible
and neoplastic. Throughout, the medium used was the same as described above
for the experiment. Whereas unaltered normal cells were incapable of sustained
multiplication in suspension cultures, the transformed cells proliferated happily
under identical conditions. Although some of these cells did attach to the glass
surface of the vessel in which they were grown in suspension, most of the cells
formed large clumps measuring up to 1-2 mm. These clumps could be serially
subcultivated in suspension.
The behaviour ofcells in tissue cultureknown as contact inhibition was also one
of the parameters by which altered cells were distinguished from the unaltered
ones. Monolayering of normal, untreated cells in these experiments reflected
the efficiency of contact inhibition and the transformed cells piled up and usually manifested a distorted random cellular array.
The only indubitable prooffor mahgnancy seemed to be the demonstration of
progressive growth of cells leading to the death of the animal when inoculated
in the appropriate host. Tumoursdeveloped in 88% inoculated BALB/c mice but
only in two rats out of 67 inoculated when newborn (a day or less than a dayold) and occasionally (33%) in mice inoculated as young adults but not rats (Tables II
and 111). Splenomegaly, quite often accompanied by hepatomegaly, developed in 90% mice, but not in rats.
Whether the cells were inoculated subcutaneously or intraperitoneally, lymphosarcoma always developed. A subcutaneous tumour was never observed
at the site of inoculation even afterinjecting a large number oftransformed cells'
The commonest sites for the tumours were on or near the mesentery, abdominal
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TABLF, II.-Results ofInoculation ofBALBIc Mice with In Vitro Transformed Cell.
A-pprox. No.
of cells Type of cells Site of Total No. Total No. of Lymphosaxcoma Lymphosarcoma inoculated inoculated inoculation of newborn young adults in newborn* in young adults
4x 105 Transformed I/P 18 15
4 x105 rat cells S/C 20 16
5X 106 Transformed I/P 15 10 15 4
5 x 101, mouse cells S/C 20 13 15 6
5X 107 Transformed I/P 10 6 9 2
5X 107 mouse cells S/C 10 4 9 1
5 x107 Transformed I/P 19 8 18 1
5X 107 rat cells S/C 19 8 17 2
5 x 101, Control I/P 35 18
5 x106 Normal cells S/C 40 10
Solid tumours in mesentery, abdominal cavity- lymph nodes, diaphragm and occasionally, the lungs and liver.
TABLE III.-Results ofInoculation ofSprague-Dawley Rats uith In Vitro Transformed Ce,118
Approx. No. No. of newborn
of cells Type of cells Site of Total No. Total No. of rats with Average latent
inociilated inoculated inoculation of newborn young adults tumours period to death
4 x 10-5 Transformed I/P 8
4 x105 rat cells S/C 8 1* 7 montbs
5 X 106 Transformed I/P 10 7
5X 106 mouse cells S/C 10 9
5X 107 Transformed I/P 8 6 1t I1 days 5X 107 ratcells S/C 8 4
5X 107 Transformed I/P 7 7
5 x107 mouse cells S/C 4 5
5X 106 Control I/P 25 15
5 x 1011 Normal cells S/C 30 20
* Only tumour of the thymus and enlarged right axillary node.
t This animal received two doses of 5 x 106cells.
andsurroundingtissue. There wereirregular masses oflymphosarcomacellssimilar
to those of solid tumours seen elsewhere, in the spleen and liver.
The earliest tumours were obtained in 10-15 days but in this case the number
of cells inoculated was 8 x 107. Most mice, if not otherwise killed, died within
7-8 months, some much earlier than this.
DISCUSSION
As the control (untreated) cells did not produce tumours when inoculated in
animals even after several months of culturing in vitro, it is deduced that the
transformation in the treated cells must have been caused by an oneogenic agent which is present not only in S37 tumour cells but is also released in the ascitic
fluid ofthe tumourbearing animals.
Alteredfoci appearinthe cultures when a cellfree extractofinvitrotransformed
cells is added to normal embryo cell cultures. An extract made from normal
TABLE IV.-Transmissibilityof the Agent In Vitro
Infection of normal
primary embryo cultures
A
Agent extracted from Mouse Rat
Transformed rat cells + +
Transformed mouse cells + + Normal rat cells
Normal mouse cells
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in vitro cultured cells remains completely inactive under similar conditions. This
indicates that the causative agent is biological and transmissible (Table IV).
The virus genome is probably present in the cells even after several months of
serial subcultivation in vitro. This is evident by the growth oftumours (lympho-
sarcomas) when both the rat and mouse cells transformed 8 months previously
in vitro are inoculated in mice.
The agent from S37 ascites tumour is completly inactivated at 56' C. for 30
minutes and both rat and mouse normalembryo cells treated with heated filtrate/
extract of the ascites tumour do not produce any lesions when inoculated in mice
or rats.
Comparison with other murine sarcoma viruses
Moloney (1960) extracted a leukaemia virus (MLV) from solid S37 tumour
tissue. Harvey, in 1964, and Moloney, in 1965/66, isolated viruses fromMLV
which produce sarcomas and other lesions in rates and mice. These agents have
been termed as Murine Sarcoma Viruses (MSV) and will be referred to as MSV
(Harvey) and MSV (Moloney) throughout the present discussion.
Since the isolation of MSV several investigators have tested the virus in vitro
as well as in vivo. Hartley and Rowe (1966), Boiron, et al. (1967) and Yoshikura,
et al. (1968) have shown that MSV (Moloney) induced morphological transforma-
tion in normal mouse embryo cultures. Similar changes have been reportedby
Simons, et al. (1967) for MSV (Harvey).
In vitro transformation of rat embryo cells by MSV (Moloney) have been des-
cribedbyTing (1966, 1967, 1968), Bernard, et al. (1967) and Boiron, et al. (1967).
Focus formation in hamster embryo cultures by MSV (Harvey) was shown by
SimonsandBassin(1967)andBoiron,etal.(1967). Thomas,etal.(1968)described
neoplastic changes in bovineembryo cellsby MSV (Moloney).
Tumour induction in mice in vivo has been demonstrated by Chesterman,
et al. (1966) by inoculating the animals with MSV (Harvey). Fefer, et al. (1967)
and Chirigos, et al. (1968) have also induced tumours in mice by inoculating MSV
(Moloney). Tumours were also produced when Chesterman, et al. (1966) and
Perk, et al. (1968) injected MSV (Harvey) and MSV (Moloney) respectively in
rats.
Merwin and Redman (1969) have shown that anagent(s) from S37 solid tumour
causes skeletal changes and reticulum tissue disorders including splenomegaly and lymphocytic neoplasms in BALB/c mice. The agent is very similar to MLV
and is derived from the same strain of S37 tumour as used by Moloney for the
extraction ofMLV and later MSV (Harvey and Moloney).
Since Merwin and Redman's paper was published in August (1969), the writer
has been examining the animals for the skeletal changes, but so far none of the
experimental animals has developed any such disorders. It is nevertheless
EXPLANATION OF PLATES
Fjio. I.-Normal mouse cultures (untreated) (x 105).
FiG. 2.-Focus formation rat culture. Normal cultures treated with 4% of S37 extract
( x 13).
FIG. 3.-Normal mouse cultures with scattered cells in various stages of alteration (x 105). Fict. 4.-Transformed mouse cells (x 105).Vol. XXV, No. 1. BRITISH JOURNAL OF CANCER.
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possible that these changes, if present in the animals autopsied before August,
1969, have beenoverlookedbecausethe writer was notspecificallylookingforthem -
However, these skeletal disorders are not peculiar to S37 Aerived agent as van
Gorp et al. (1969), Upton and Furth (1955) and many others have observed similar
changes in animdls with viruses other than usedby Merwin and Redman (1969).
As far as morphological transformation of mouse and rat embryo cells in vitro
is concemed, the present agent from S37 ascites tumour, appears to be related to
MSV (Harvey and Moloney). Like MSV this agent is also inactivated at 56' C.
for 30 minutes but at 37' C. for this period, the infectivity is unimpaired. It,
however, differs from MSV in thefollowing features:
Whereas with MSV (Harvey) the site of tumour depends on the route of
inoculation, the present agent produces the same type of tumour, i.e, a lympho-
sarcoma, no matter how the cells are introduced in animals. Solid subcutaneous
tumours are developed at the site of inoculation with MSV (Harvey) but no such
tumours have ever been observed in the writer's experimental animals. Even
when a large number of cells (8 x 107) are inoculated subcutaneously a lympho-
sarcoma is developed. This indicates that the tumours are produced, not by
local growth of cells, but by the agent being carried by the lymphatic system to
various parts ofthe body and causingneoplastic changes. Tumours obtained by
inoculation of in vitro transformed cells have been serially passaged in mice by
subcutaneous orintraperitoneal routes. In both caseslymphosarcomadeveloped.
After nearly 13 months of serial subcutaneous transplantation of tumours in
vivo (15th to 18th passage) there is now a slight evidence of a few cells of one
particular tumour line, growing flat under the skin at the site of inoculation.
Even this feature always accompanies a lymphosarcoma. However, it appears
that the subcutaneous growth is due to the adaptation in vivo after prolonged
serialtransplantation.
Pleural effusions and cystic swell'ings in the region oflymph nodes and other
organs occur very frequently i'n animals inoculated with MSV (Harvey). No
such lesions or serosal reactions have ever been located in any of the several
hundred animals examined during routine autopsies.
Anothermajor difference between the agent from S37 ascites tumour and MSV
(Harvey andMoloney) is that whereas the latter strains produce tumours in both
rats and mice the present isolate onlydevelops tumours in mice. Rat cells which
were transformed in vitroby the S37 ascites tumour, failed toproduce tumours or
other lesions when inoculated in rats. Both rat and mouse embryo cells trans-
formed in vitro, readily induce tumours in mice. Only 2 rats out of 67 inoculated
when newborn with in vitro transformed rat cells developed tumours. One rat
which had very much enlarged thymus and the right axillary node died after
7 months, and the other which was inoculated with transformed cells twice
within aweek, died after I1 days. The first inoculation ofceRs was 12 hours after
birth and the second followed after 7 days ofthe first inoculation. Post-mortem
examination revealed a mass of neoplastic cells fiHing the abdominal cavity. The first rat which died could have had spontaneous tumours, but the causes
for the second rat's death are very intriguing; as the rest of the rats from the
same litter which were inoculated twice at the same times as the one which died,
seemed to have developed resistance to the production of tumour. The reason
for this characteristic resistance of rats to the present biological agent are still
undetermined.148 S.RASHEED
Although haemagralutination and other specific tests were not carried out, the
evidence isstronglyagainstthepossibilitythat an admixture ofpolyoma virus may
be responsible for tumour production. No salivary gland tumours, which are
characteristic ofpolyoma virus, have ever been observed. The present agent is
inactivated at 56' C. for 30 minutes whereaspolyoma resists it.
Since the transformations occurred in a laboratory in which any other virus
was not handled, the repeated transmission of the agent in the mouse and rat
embryo cells invitro, implies the presence of a virus or viruses.
Whether the tumorigenic properties of the agent from S37 asictes tumour are
due to a mutant ofMLV or MSV or to a latent
" passenger
" virus present speci-
fically in BALB/c ascites tumour or to a mixture of such a virus withMoloney
virus is still to be determined. It is possible that the extract of this tumour
contains more than one agent.
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